6919.TW
6919.TW
TW0006919004
CALIWAY BIOPHARMACEUTICALS CO L
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
120.62B EUR
155.33B EUR
134.31B EUR
240.71B EUR
Enterprise Value
116.6B EUR
152.39B EUR
131.78B EUR
239.93B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
14.43x
--
--
--
Price to Sales
4,103.71x
5,284.51x
3,530.97x
6,328.35x
Price to Book
13.09x
16.87x
14.35x
25.58x
EV/Revenue
3,967.08x
5,184.52x
3,464.22x
6,307.81x
EV/EBITDA
-144.21x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-0.38%
-0.19%
-0.26%
-0.13%
ende